The tissue proteome in the multi-omic landscape of kidney disease

• Verfasst von: Rinschen, Markus Matthias [VerfasserIn]
• Verfasst von: Sáez Rodríguez, Julio [VerfasserIn]
• Titel: The tissue proteome in the multi-omic landscape of kidney disease
• Verf.angabe: Markus M. Rinschen, Julio Saez-Rodriguez
• E-Jahr: 2021
• Jahr: March 2021
• Umfang: 15 S.
• Fussnoten: Zuerst online veröffentlicht: 07 October 2020 ; Gesehen am 24.02.2025
• Titel Quelle: Enthalten in: Nature reviews. Nephrology
• Ort Quelle: Basingstoke : Nature Publishing Group, 2009
• Jahr Quelle: 2021
• Band/Heft Quelle: 17(2021), 3 vom: März, Seite 205-219
• ISSN Quelle: 1759-507X
• DOI: doi:10.1038/s41581-020-00348-5
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Computational biology and bioinformatics
• Sach-SW: Glomerular diseases
• Sach-SW: Podocytes
• Sach-SW: Proteomics
• K10plus-PPN: 1917915217

Abstract

Kidney research is entering an era of ‘big data’ and molecular omics data can provide comprehensive insights into the molecular footprints of cells. In contrast to transcriptomics, proteomics and metabolomics generate data that relate more directly to the pathological symptoms and clinical parameters observed in patients. Owing to its complexity, the proteome still holds many secrets, but has great potential for the identification of drug targets. Proteomics can provide information about protein synthesis, modification and degradation, as well as insight into the physical interactions between proteins, and between proteins and other biomolecules. Thus far, proteomics in nephrology has largely focused on the discovery and validation of biomarkers, but the systematic analysis of the nephroproteome can offer substantial additional insights, including the discovery of mechanisms that trigger and propagate kidney disease. Moreover, proteome acquisition might provide a diagnostic tool that complements the assessment of a kidney biopsy sample by a pathologist. Such applications are becoming increasingly feasible with the development of high-throughput and high-coverage technologies, such as versatile mass spectrometry-based techniques and protein arrays, and encourage further proteomics research in nephrology.